Gilead Sciences, Inc. (TSX:GILD)
Canada · Delayed Price · Currency is CAD 28.97
-0.15 (-0.52%)
Oct 6, 2026, 3:42 PM EST
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of CAD 254.31 billion as of October 6, 2026. Its market cap has increased by 30.38% in one year.
Market Cap
254.31B
Enterprise Value
284.57B
Revenue
43.25B
Ranking
n/a
PE Ratio
n/a
Stock Price
28.97
ChartMarket Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 289.43M to 254.31B, an increase of 87,764.79%. That is a compound annual growth rate of 21.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 254.31B | 21.80% |
| Dec 31, 2025 | 208.80B | 26.06% |
| Dec 31, 2024 | 165.64B | 24.25% |
| Dec 29, 2023 | 133.31B | -8.53% |
| Dec 30, 2022 | 145.73B | 26.44% |
| Dec 31, 2021 | 115.26B | 23.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apotex Health | 7.12B |
| Curaleaf Holdings | 3.69B |
| Extendicare | 2.55B |
| Sienna Senior Living | 2.17B |
| Green Thumb Industries | 2.06B |
| Cronos Group | 1.72B |
| WELL Health Technologies | 1.12B |
| Knight Therapeutics | 1.02B |